Teresa Nunes

CATO SMS engages in the research and development of oncology, cell and gene therapy, and rare treatments, which supports the small and mid-sized biotech and pharmaceutical companies. Its services include clinical trial operations, regulatory consulting, medical affairs and pharmacovigilance, strategy and consulting, data management and biostats, and preclinical and nonclinical. The company was founded in 2019 and is headquartered in Schiphol, the Netherlands.

CATO SMS engages in the research and development of oncology, cell and gene therapy, and rare treatments, which supports the small and mid-sized biotech and pharmaceutical companies. Its services include clinical trial operations, regulatory consulting, medical affairs and pharmacovigilance, strategy and consulting, data management and biostats, and preclinical and nonclinical. The company was founded in 2019 and is headquartered in Schiphol, the Netherlands.

CATO SMS engages in the research and development of oncology, cell and gene therapy, and rare treatments, which supports the small and mid-sized biotech and pharmaceutical companies. Its services include clinical trial operations, regulatory consulting, medical affairs and pharmacovigilance, strategy and consulting, data management and biostats, and preclinical and nonclinical. The company was founded in 2019 and is headquartered in Schiphol, the Netherlands.